We not only demonstrated ANPG was an significantly independent prognostic factor for NSCLC patients and patients with high ANPG seemed to have more chance to live in poor prognosis, but also found ANPG outperformed better than either albumin or neutrophil for predicting outcome and making therapeutic decisions for NSCLC. Here, ALB is linked to non-small cell lung carcinoma.